Anaemia - PowerPoint PPT Presentation

1 / 33
About This Presentation
Title:

Anaemia

Description:

Idiopathic thrombocytopenic purpura (ITP) Microangiopathies: ... Idiopathic Thrombocytopenic ... Idiopathic Thrombocytopenic Purpura (ITP) Maternal haemorrhage ... – PowerPoint PPT presentation

Number of Views:192
Avg rating:3.0/5.0
Slides: 34
Provided by: ses92
Category:

less

Transcript and Presenter's Notes

Title: Anaemia


1
Anaemia Thrombocytopenia in Pregnancy
  • Giselle Kidson-Gerber
  • Haematology Registrar
  • Prince of Wales Hospital

2
Anaemia in pregnancy
3
Physiological changes in normal pregnancy
  • RBC dilution with rise in blood volume and plasma
    volume
  • Definition of anaemia in pregnancy
  • T1, T3 Hb lt 110g/L
  • T2 Hb lt 105g/L
  • Return to normal within 1 week post-partum, if
    normal iron stores

4
Potential consequences of moderate to severe
anaemia
  • Maternal
  • Fatigue, dyspnoea, syncope, chest pain
  • Mortality (esp lt 50g/L)
  • Foetal (esp lt 60g/L)
  • Impaired mental development if low iron stores
  • Low birth weight
  • Preterm labour
  • Perinatal death
  • Low amniotic fluid volume
  • Spontaneous miscarriage
  • Placental Hypertrophy

5
Common causes of anaemia in pregnancy
6
Preconception
  • Assess nutrition status
  • Full blood count
  • Investigate if anaemia present
  • Correct anaemia prior to conception
  • Haemoglobinopathy screening

7
Investigations
  • FBC, with MCV, blood film
  • Fe studies ferritin esp.
  • Folate (RCF stores) B12 levels
  • Reticulocyte count
  • UEC, LFT, Coagulation studies
  • Haemoglobinopathy screening

8
Iron deficiency anaemia
  • Most common cause in Western countries
  • Increased iron requirements during pregnancy,
  • especially multiple pregnancies
  • Replace Ferrous sulfate 325mg tds (105mg
    elemental Fe)
  • Anaemia corrects in 4 - 6 weeks
  • Stores replaced in 4 - 6 months
  • Dietary advice
  • Once replete
  • Ongoing supplement 30 - 60mg elemental iron
    daily
  • Monitor, including whilst breastfeeding

9
Iron therapies
10
Folic Acid deficiency
  • 2nd most common cause of anaemia in pregnancy
  • Increased requirements for mother and foetus
  • Red cell folate measure more reflective of
    tissue stores over past months
  • Supplement all 200 - 500mcg/d
  • (greater if haemolysis)
  • Replacement 1000mcg/d

11
Haemoglobinopathies Practical significance
  • Major haemoglobinopathy in mother
  • Rare
  • Specialist obstetric haematology care
  • Haemoglobinopathy traits in mother
  • Silent risk foetus
  • Transfusion-dependent anaemia or sickle cell
    disease
  • Barts disease/hydrops foetalis maternal foetal
    morbidity
  • Dependent on maternal and paternal genotype
  • Importance of appropriate timely screening

12
Difficulties with detection of haemoglobinopathy
traits
  • Patient asymptomatic
  • Patient unaware of carrier status
  • Difficult to detect in laboratory
  • May have normal Hb or MCV
  • Haemoglobinopathy screening does not
    detect all cases
  • Iron deficiency can mask indicator of
    thalassaemia trait

13
Haemoglobinopathies
14
Screening
  • Why? - Detect foetus at risk of major
    haemoglobinopathy
  • Who? - At risk ethnic groups, ? all
  • (Southern Europe, Middle East, Africa, Asia,
    Indian subcontinent)
  • - Mother partner
  • When? - Ideally preconception
  • - Limited timeframe for Ix intervention
  • What? - FBC Hb, MCV
  • - HbEPG (includes HPLC, HbH bodies)

15
Full blood count
  • Simple
  • Limitations
  • ? MCV may not detect - a thalassaemia trait
    - sickle trait
  • ? Hb may not detect - ß thalassaemia trait
  • - a thalassaemia trait - sickle
    trait
  • Iron deficiency must be excluded as cause of low
    MCV

16
HbEPG Hb Electrophoresis
  • Separates different haemoglobins according to
    charge
  • Alkaline acid gels
  • Known position of haemoglobin bands

HbF
HbA
HbS
HbA2,C,E
HbS trait
Control
Normal
ß thalassaemia trait
HbE trait
HbE disease
17
HPLC High Performance Liquid Chromatography
  • Separate according to elution time
  • Quantify of different haemoglobins present
  • Iron deficiency lowers HbA2

Normal
HbS trait
HbS band 39
HbA predominant haemoglobin 88
HbA 50
18
When to refer or ask for help
  • Positive result
  • Unexplained anaemia
  • Uncertain what investigations to perform
  • Uncertain how to interpret investigations
  • Complex area!
  • Variation in conditions and test results
  • Specialist services are available DNA testing
    is readily available should be accessed when
    there is doubt

19
DNA testing
  • Confirm results or clarify unclear results
  • Test mother partner
  • Foetus
  • If have a known mutation in both parents
  • Usually gives definitive genotype, although not
    100 predictive of phenotype
  • Formal genetic counselling prior
  • Must be organised EARLY in pregnancy
  • - ideally preconception.
  • Option of prenatal genetic diagnosis with IVF

20
Take home message
  • Evaluate anaemia PRIOR to pregnancy
  • Determine cause of low MCV
  • Replace iron, if deficient
  • Low threshold for haemoglobinopathy screening and
    referral

21
Thrombocytopenia in pregnancy
22
Thrombocytopenia
  • Physiological thrombocytopenia in normal
    pregnancy
  • Average decrease in platelet count of 10
  • Occurs mostly in 3rd trimester
  • Due to haemodilution or accelerated destruction
  • Normalises 24 -72 hours post-partum
  • Complicated Thrombocytopenia
  • Up to 10 of pregnancies
  • Mild - 100 - 150 x 109/L
  • Moderate - 50 - 100 x 109/L
  • Severe - lt 50 x 109/L

23
Causes of Thrombocytopenia in Pregnancy
  • Pregnancy-specific
  • Increased destruction
  • Gestational
  • Preeclampsia
  • HELLP
  • Acute Fatty Liver of Pregnancy
  • Disseminated intravascular coagulopathy
  • Non-pregnancy-specific
  • Increased destruction
  • Idiopathic thrombocytopenic purpura (ITP)
  • Microangiopathies TTP, HUS, DIC
  • SLE, Antiphospholipid syndrome
  • Drug-induced
  • Viral infections HIV, HCV, EBV, CMV
  • Hypersplenism
  • Decreased production
  • Bone Marrow Disease
  • Nutritional deficiency
  • Liver disease
  • Congenital thrombocytopenia

24
Causes of Thrombocytopenia in Pregnancy
  • Pregnancy-specific
  • Increased destruction
  • Gestational
  • Preeclampsia
  • HELLP
  • Acute Fatty Liver of Pregnancy
  • Disseminated intravascular coagulopathy
  • Non-pregnancy-specific
  • Increased destruction
  • Idiopathic thrombocytopenic purpura (ITP)
  • Microangiopathies TTP, HUS, DIC
  • SLE, Antiphospholipid syndrome
  • Drug-induced
  • Viral infections HIV, HCV, EBV, CMV
  • Hypersplenism
  • Decreased production
  • Bone Marrow Disease
  • Nutritional deficiency
  • Liver disease
  • Congenital thrombocytopenia

25
Causes of Thrombocytopenia in Pregnancy
  • Pregnancy-specific
  • Increased destruction
  • Gestational
  • Preeclampsia
  • HELLP
  • Acute Fatty Liver of Pregnancy
  • Disseminated intravascular coagulopathy
  • Non-pregnancy-specific
  • Increased destruction
  • Idiopathic thrombocytopenic purpura (ITP)
  • Microangiopathies TTP, HUS, DIC
  • SLE, Antiphospholipid syndrome
  • Drug-induced
  • Viral infections HIV, HCV, EBV, CMV
  • Hypersplenism
  • Decreased production
  • Bone Marrow Disease
  • Nutritional deficiency
  • Liver disease
  • Congenital thrombocytopenia

26
Causes of Thrombocytopenia in Pregnancy
  • Pregnancy-specific
  • Increased destruction
  • Gestational
  • Preeclampsia
  • HELLP
  • Acute Fatty Liver of Pregnancy
  • Disseminated intravascular coagulopathy
  • Non-pregnancy-specific
  • Increased destruction
  • Idiopathic thrombocytopenic purpura (ITP)
  • Microangiopathies TTP, HUS, DIC
  • SLE, Antiphospholipid syndrome
  • Drug-induced
  • Viral infections HIV, HCV, EBV, CMV
  • Hypersplenism
  • Decreased production
  • Bone Marrow Disease
  • Nutritional deficiency
  • Liver disease
  • Congenital thrombocytopenia

27
Clinical approach
  • Symptoms, bleeding history
  • Prenatal platelet count
  • Gestation
  • Previous pregnancies
  • Associated features
  • Co-morbidities

28
Gestational Thrombocytopenia
  • Occurs in 5-8 of all pregnancies
  • 75 of all pregnancy-associated thrombocytopenia
  • ? Mechanism haemodilution, accelerated plt
    turnover, trapping or destruction at placenta
  • Maternal haemorrhage risk not increased
  • Foetal thrombocytopenia risk not increased

29
Gestational Thrombocytopenia
  • Clinically - asymptomatic
  • - normal pre-natal platelet count
  • - occurs in late T2 in T3
  • - normalises post-partum
  • Mild thrombocytopenia
  • Platelet count gt 70 x109/L (usually gt 100)
  • Anti-platelet antibodies do not reliably
    distinguish from ITP
  • Diagnosis of exclusion

30
Idiopathic Thrombocytopenic Purpura (ITP)
  • 5 of pregnancy-associated thrombocytopenia, 0.1
    of pregnancies
  • Concern maternal and foetal haemorrhage
  • Clinically - any trimester
  • - prenatal thrombocytopenia
  • - bleeding history
  • Especially likely to be ITP if
  • Platelet count lt50 x109/L
  • T1
  • History of auto-immune disease

31
Idiopathic Thrombocytopenic Purpura (ITP)
  • Maternal haemorrhage risk increased,
  • relates to platelet count
  • Platelet count lt 20 risk of spontaneous bleeding
  • Platelet count gt 50 aim for NVD
  • Platelet count gt 70 for epidural (variable,
    anaesthetist preference)
  • Foetal thrombocytopenia
  • due to trans-placental passage of maternal
    IgG
  • 10-20 platelet count lt 50 x109/L
  • 5 platelet count lt 20 x109/L 25-50 develop
    bleeding
  • Best predictor sibling
  • Check cord platelet count at delivery, nadir day
    2-3.
  • Therapeutic options monitor only, IVIg,
    prednisone, (splenectomy)

32
Summary of approach to thrombocytopenia in
pregnancy
  • Exclude pre-eclampsia syndromes
  • BP, UA, symptoms, FBC, UEC, LFT, Uric Acid
  • Exclude non-pregnancy-related medical causes,
    usually have specialist involved already
  • When to refer
  • Known history of ITP
  • Unknown cause platelet count is
  • lt130 x 109/L in T1 T2
  • lt100 x 109/L in T3
  • Otherwise monitor FBC monthly

33
  • Thank-you
Write a Comment
User Comments (0)
About PowerShow.com